Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employeeswho bringdifferent and innovativeways of seeing the world and solving problems.Fred Hutch is in pursuit of becoming an antiracist organization.Weare committed to ensuring that all candidates hired share our commitment to diversity,antiracism, and inclusion.
We have an opening for a BioinformaticianI in the Bedford lab to work on genomic epidemiology and evolutionary analysis of pathogens including SARS-CoV-2, influenza and Ebola virus. This position will contribute to ongoing work on two major projects: Nextstrain and Seattle Flu Study.
The Seattle Flu Study is a collaboration of groups at the Brotman Baty Institute, the Fred Hutch, the University of Washington, and Seattle Childrens. Already in its third year, this study has produced high-resolution analyses of the spread of SARS-CoV-2 and influenza in Seattle by building a software platform that processes subject and sample metadata, lab assay results, and raw and processed genome data in near-real time.
The role involves both development and maintenance of bioinformatic analyses and pipelines which underpin both projects research aims. This will involve a mixture of independent work, collaboration with scientists in the group and interactions with the wider community. The vast majority of code is open-source. Specific examples from Nextstrain include analytic pipelines that clean and ingest genome metadata, construct consensus genomes, and build phylogenetic trees, as well as tools to enable a diverse range of collaborators to run SARS-CoV-2 analyses through Nextstrain.
Work on Seattle Flu Study focuses on pipelines to assemble raw sequence data into consensus SARS-CoV-2 and influenza genomes and deposition of these consensus genomes to public databases.
Interfacing with project collaborators in-person and online is a key aspect of this position. The bioinformatician will work within a small team of existing members of the Bedford lab and the larger research group of the Seattle Flu Study. The Nextstrain team communicates openly about project and organizational decisions and encourages participation by all team members in the decision-making process.
Knowledge of molecular biology
Knowledge of Biostatistics, Bioinformatics or Computational Biology
Knowledge of working in a lab environment
Motivated to learn new skills and technologies
Execellent written and verbal communication skills
Expertise in genomics
Experience writing biostatistic analysis programs with biological decisions
BS degree in a Biology discipline
Experience with pipeline or workflow automation
Familiarity with software development best practices
Experience configuring and deploying analyses on a cloud infrastructure
Experience and willingness to participate in team decision-making processes
To be considered for this position:
Candidates must provide a coding sample by submitting it with their application.
The hiring team will review any programming lanquage you choose.
Please provide either a zipped up project included as an "additional attachment" OR,
Please provide a link to a specific repo online by attaching a short statement pointing to the URL of this repo as an "additional attachment" to your application.
Please name this zip archive / file as "last name_job ID_coding sample".
If you don't have code that can be publicly shared, please notate this in your application.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.